Edap Tms SA (NASDAQ:EDAP) was the target of a significant increase in short interest in June. As of June 30th, there was short interest totalling 52,000 shares, an increase of 29.7% from the May 30th total of 40,100 shares. Approximately 0.2% of the shares of the company are short sold. Based on an average daily volume of 177,200 shares, the days-to-cover ratio is currently 0.3 days.
A hedge fund recently bought a new stake in Edap Tms stock. Hilton Capital Management LLC purchased a new position in Edap Tms SA (NASDAQ:EDAP) during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 25,000 shares of the medical equipment provider’s stock, valued at approximately $75,000. Hilton Capital Management LLC owned approximately 0.09% of Edap Tms at the end of the most recent quarter. 10.31% of the stock is currently owned by hedge funds and other institutional investors.
EDAP has been the topic of a number of recent analyst reports. Zacks Investment Research upgraded shares of Flagstar Bancorp from a “hold” rating to a “buy” rating and set a $38.00 price objective on the stock in a research note on Monday, July 8th. HC Wainwright set a $4.00 price target on shares of Uranium Energy and gave the stock a “buy” rating in a research report on Tuesday, June 11th. ValuEngine upgraded shares of YY from a “sell” rating to a “hold” rating in a research report on Friday, June 7th. Finally, TheStreet cut shares of Timkensteel from a “c-” rating to a “d+” rating in a research report on Monday, June 17th.
EDAP traded down $0.01 during trading on Friday, reaching $2.70. The company had a trading volume of 33,287 shares, compared to its average volume of 69,717. The company has a 50-day moving average of $2.80. The firm has a market capitalization of $78.30 million, a P/E ratio of 135.00 and a beta of 1.94. Edap Tms has a 12-month low of $1.35 and a 12-month high of $5.42. The company has a current ratio of 2.40, a quick ratio of 1.97 and a debt-to-equity ratio of 0.09.
Edap Tms (NASDAQ:EDAP) last issued its quarterly earnings results on Wednesday, May 15th. The medical equipment provider reported $0.01 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.01. The firm had revenue of $11.50 million for the quarter, compared to analysts’ expectations of $13.25 million. Edap Tms had a negative return on equity of 1.13% and a negative net margin of 0.36%. Analysts anticipate that Edap Tms will post 0.08 earnings per share for the current fiscal year.
About Edap Tms
EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS).
Recommended Story: What is a trade deficit?
Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.